Sleep Related Breathing Disturbances and High Altitude Pulmonary Hypertension in Kyrgyz Highlanders
Sleep Apnea and High Altitude Pulmonary Hypertension in Kyrgyz Highlanders
1 other identifier
observational
125
1 country
1
Brief Summary
High altitude pulmonary hypertension, a form of altitude illness that occurs in long-term residents at altitudes \>2500 m, is characterized by dyspnea, hypoxemia, impaired exercise performance and hypertension in the pulmonary circulation. Whether sleep related breathing disturbances, common causes of nocturnal hypoxemia in lowlanders, are also prevalent in highlanders and promote pulmonary hypertension in highlanders is unknown. Therefore, the current study will investigate whether highlanders with high altitude pulmonary hypertension have a greater prevalence of sleep apnea than healthy highlanders and lowlanders.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2012
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2012
CompletedFirst Submitted
Initial submission to the registry
June 13, 2012
CompletedFirst Posted
Study publicly available on registry
June 15, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2013
CompletedMay 15, 2014
May 1, 2014
1.5 years
June 13, 2012
May 14, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Sleep related breathing disturbances
Nocturnal oxygen saturation and apnea/hypopnea index
4 months
Secondary Outcomes (10)
Pulmonary artery pressure
4 months
Dyspnea
4 months
Vigilance
4 months
Exercise performance
4 months
Pulmonary function
4 months
- +5 more secondary outcomes
Study Arms (3)
High altitude pulmonary hypertension
Highlanders with high altitude pulmonary hypertension
High altitude control
Healthy highlanders
Low altitude control
Healthy lowlanders
Eligibility Criteria
Highlanders with high altitude pumonary hypertension living at an altitude of 2500-4000 m; healthy highlanders living at an altitude of 2500-4000 m; healthy lowlanders living at an altitude of \<1000 m.
You may qualify if:
- high altitude pulmonary hypertension confirmed by clinical presentation and systolic pulmonary artery pressure \>50 mmHg measured by echocardiography at altitude of residence.
- healthy subjects (high altitude controls)
- Both genders
- Age \>16 y
- Kyrgyz ethnicity
- born, raised and currently living at \>2500 m
- healthy subjects currently living at \<1000 m (low altitude controls)
You may not qualify if:
- Pulmonary hypertension from other causes, in particular from left ventricular failure as judged clinically and by echocardiography
- excessive erythrocytosis
- other coexistent disorders that may interfere with the cardio-respiratory system and sleep
- regular use of medication that affects control of breathing
- heavy smoking
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Center for Cardiology and Internal Medicine
Bishkek, 720040, Kyrgyzstan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Konrad E Bloch, MD
University of Zurich, Switzerland
- PRINCIPAL INVESTIGATOR
Talant Sooronbaev, MD
National Center of Cardiology and Internal Medicine named after academician M.Mirrakhimov
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
June 13, 2012
First Posted
June 15, 2012
Study Start
June 1, 2012
Primary Completion
December 1, 2013
Study Completion
December 1, 2013
Last Updated
May 15, 2014
Record last verified: 2014-05